| AXA WORLD FUNDS-GLOBAL SMALL CAP EQUITY QI F CAP EUR HEDGED | RVI GLOBAL SMALL/MID CAP | · | -5,43% | -33,30% | · |
| JPM THEMATICS-GENETIC THERAPIES D (ACC) USD | BIOTECNOLOGÍA | 17,90% | 3,65% | -33,34% | · |
| TEMPLETON GLOBAL BOND A (MDIS) AUD-H1 | RFI GLOBAL | 10,34% | -13,52% | -33,37% | -51,08% |
| AXA WORLD FUNDS-EURO LONG DURATION BONDS I DIS EUR | RF EURO LARGO PLAZO | 0,23% | -1,02% | -33,39% | -19,33% |
| AXA WORLD FUNDS-EURO LONG DURATION BONDS A DIS EUR | RF EURO LARGO PLAZO | 0,23% | -1,02% | -33,40% | -19,04% |
| AMUNDI S.F. - EURO CURVE 10+ YEAR E CAP EUR | RF EURO LARGO PLAZO | 2,12% | 0,42% | -33,43% | -17,69% |
| GOLDMAN SACHS EMERGING MARKETS DEBT PORTFOLIO I H JPY CAP | RFI EMERGENTES | -5,53% | -6,46% | -33,55% | · |
| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 25,31% | 13,93% | -33,58% | · |
| JPM CHINA C (DIST) USD | RVI CHINA | 2,87% | 2,05% | -33,62% | 88,32% |
| TEMPLETON CHINA I (YDIS) GBP | RVI CHINA | 9,46% | 11,35% | -33,62% | 41,92% |
| UBS (LUX) EQUITY SICAV - ALL CHINA (USD) Q-ACC | RVI CHINA | 3,63% | 7,95% | -33,62% | · |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 25,25% | 13,79% | -33,71% | · |
| BELLEVUE FUNDS (LUX) - BELLEVUE ASIA PACIFIC HEALTHCARE I2 CHF | SALUD | 3,87% | -10,63% | -33,72% | · |
| BELLEVUE FUNDS (LUX) - BELLEVUE ASIA PACIFIC HEALTHCARE I2 USD | SALUD | 4,39% | -11,50% | -33,72% | · |
| BELLEVUE FUNDS (LUX) - BELLEVUE ASIA PACIFIC HEALTHCARE I2 EUR | SALUD | 4,26% | -10,70% | -33,73% | · |
| BELLEVUE FUNDS (LUX) - BELLEVUE ASIA PACIFIC HEALTHCARE I EUR | SALUD | 4,22% | -10,79% | -33,74% | · |
| TEMPLETON CHINA W (YDIS) EUR | RVI CHINA | 9,84% | 11,45% | -33,76% | 38,06% |
| BELLEVUE FUNDS (LUX) - BELLEVUE ASIA PACIFIC HEALTHCARE I USD | SALUD | 4,35% | -11,59% | -33,77% | · |
| TEMPLETON CHINA W (ACC) EUR | RVI CHINA | 9,85% | 11,50% | -33,77% | 44,34% |
| BELLEVUE FUNDS (LUX) - BELLEVUE ASIA PACIFIC HEALTHCARE I CHF | SALUD | 3,83% | -10,78% | -33,85% | · |
